Ambu (AMBU-B.CO) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Ambu (AMBU-B.CO) quarterly earnings & revenue
Ambu (AMBU-B.CO) reported revenue of 240.09M DKK for Q2 2026, up 1.2% year-over-year, with net income of 18.47M DKK and diluted EPS of 0.07 DKK.
Over the last four reported quarters, Ambu generated 931.65M DKK in revenue and 72.80M DKK in net income.
Ambu's next earnings report is scheduled for August 26, 2026; analysts estimate EPS of 0.09 DKK.
Ambu quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q2 2026 | 240.09M DKK | +1.2% | 18.47M DKK | 0.07 DKK |
| Q1 2026 | 237.80M DKK | +3.2% | 18.01M DKK | 0.07 DKK |
| Q4 2025 | 223.76M DKK | +5.7% | 17.55M DKK | 0.07 DKK |
| Q3 2025 | 230.01M DKK | +9.0% | 18.77M DKK | 0.07 DKK |
| Q2 2025 | 237.19M DKK | +13.7% | 28.69M DKK | 0.11 DKK |
| Q1 2025 | 230.47M DKK | +20.4% | 27.93M DKK | 0.10 DKK |
| Q4 2024 | 211.70M DKK | +10.2% | -20.61M DKK | -0.08 DKK |
| Q3 2024 | 211.09M DKK | +15.7% | 20.45M DKK | 0.08 DKK |
Ambu (AMBU-B.CO) — frequently asked questions
When does Ambu (AMBU-B.CO) report earnings next?
Ambu is expected to report earnings on August 26, 2026. Analysts estimate EPS of 0.09 DKK.
What was AMBU-B.CO's revenue last quarter?
Ambu reported revenue of 240.09M DKK in Q2 2026, up 1.2% from the same quarter a year earlier.
What was AMBU-B.CO's EPS last quarter?
Ambu reported diluted EPS of 0.07 DKK in Q2 2026.
Is Ambu profitable?
Ambu is currently profitable, with 72.80M DKK in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)